Abstract

The present invention relates to a crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol.


Claims
Download PDF
Document Preview
Document History
  • Publication: Aug 20, 2019
  • Application: May 19, 2016
    US US 201615575332 A
  • Priority: May 19, 2016
    EP EP 2016061200 W
  • Priority: May 20, 2015
    EP EP 2015061153 W

Download Citation


Sign in to the Lens

Feedback